“Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea”, ajm, vol. 9, no. 2, pp. 201–205, Oct. 2026, doi: 10.48165/ajm.2026.9.02.34.